GDNF family ligand dependent STAT3 activation is mediated by specific alternatively spliced isoforms of GFRα2 and RET

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 12, 2013, Pages 2789-2802

  Zhou, Lihan ^a,c   Too, Heng Phon ^a,b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c AGENCY FOR SCIENCE   (Singapore)

Author keywords

GDNF; GFR 2; Mitochondrial STAT3; NRTN; Receptor isoform; RET

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR FAMILY RECEPTOR ALPHA 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MUTANT PROTEIN; NERVE CELL ADHESION MOLECULE; NEURTURIN; PROTEIN RET; PROTEIN RET 9; SERINE; SMALL INTERFERING RNA; STAT3 PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; BRAIN CELL; BRAIN MITOCHONDRION; CONTROLLED STUDY; HYPOTHESIS; IMMUNOBLOTTING; NERVE CELL; NERVE FIBER GROWTH; NEUROBLASTOMA CELL; NONHUMAN; PC12 CELL; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STABLE TRANSFECTION; TRANSCRIPTION INITIATION; TRANSIENT EXPRESSION; TRANSIENT TRANSFECTION; WILD TYPE;

EID: 84882806997     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.07.004     Document Type: Article

References (55)

1. Paratcha G., Ledda F. GDNF and GFRalpha: a versatile molecular complex for developing neurons. Trends Neurosci. 2008, 31:384-391.
2. Takahashi M. The GDNF/RET signaling pathway and human diseases. Cytokine Growth Factor Rev. 2001, 12:361-373.
3. Paratcha G., Ledda F., Ibanez C.F. The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. Cell 2003, 113:867-879.
4. Sariola H., Saarma M. Novel functions and signalling pathways for GDNF. J. Cell Sci. 2003, 116:3855-3862.
5. Karim F., Hu H.J., Adwanikar H., Kaplan D., Gereau R.W.t. Impaired inflammatory pain and thermal hyperalgesia in mice expressing neuron-specific dominant negative mitogen activated protein kinase kinase (MEK). Mol. Pain 2006, 2:2.
6. Yan H., Keast J.R. Neurturin regulates postnatal differentiation of parasympathetic pelvic ganglion neurons, initial axonal projections, and maintenance of terminal fields in male urogenital organs. J. Comp. Neurol. 2008, 507:1169-1183.
7. Paveliev M., Airaksinen M.S., Saarma M. GDNF family ligands activate multiple events during axonal growth in mature sensory neurons. Mol. Cell. Neurosci. 2004, 25:453-459.
8. Wong Y.W., Too H.P. Identification of mammalian GFRalpha-2 splice isoforms. NeuroReport 1998, 9:3767-3773.
9. Wan G., Zhou L., Lim Q., Wong Y.H., Too H.P. Cyclic AMP signalling through PKA but not Epac is essential for neurturin-induced biphasic ERK1/2 activation and neurite outgrowths through GFRalpha2 isoforms. Cell. Signal. 2011, 23:1727-1737.
10. Yoong L.F., Too H.P. Glial cell line-derived neurotrophic factor and neurturin inhibit neurite outgrowth and activate RhoA through GFR alpha 2b, an alternatively spliced isoform of GFR alpha 2. J. Neurosci. 2007, 27:5603-5614.
11. Tsui-Pierchala B.A., Ahrens R.C., Crowder R.J., Milbrandt J., Johnson E.M. The long and short isoforms of Ret function as independent signaling complexes. J. Biol. Chem. 2002, 277:34618-34625.
12. Povlsen G.K., Ditlevsen D.K. The neural cell adhesion molecule NCAM and lipid rafts. Adv. Exp. Med. Biol. 2010, 663:183-198.
13. Dziennis S., Alkayed N.J. Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration. Rev. Neurosci. 2008, 19:341-361.
14. Reich N.C., Liu L. Tracking STAT nuclear traffic. Nat. Rev. Immunol. 2006, 6:602-612.
15. Yokogami K., Wakisaka S., Avruch J., Reeves S.A. Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr. Biol. 2000, 10:47-50.
16. Chung J., Uchida E., Grammer T.C., Blenis J. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol. Cell. Biol. 1997, 17:6508-6516.
17. Shulga N., Pastorino J.G. GRIM-19 mediated translocation of STAT3 to mitochondria is necessary for TNF induced necroptosis. J. Cell Sci. 2012.
18. Wegrzyn J., Potla R., Chwae Y.J., Sepuri N.B., Zhang Q., Koeck T., Derecka M., Szczepanek K., Szelag M., Gornicka A., Moh A., Moghaddas S., Chen Q., Bobbili S., Cichy J., Dulak J., Baker D.P., Wolfman A., Stuehr D., Hassan M.O., Fu X.Y., Avadhani N., Drake J.I., Fawcett P., Lesnefsky E.J., Larner A.C. Function of mitochondrial Stat3 in cellular respiration. Science 2009, 323:793-797.
19. Schuringa J.J., Wojtachnio K., Hagens W., Vellenga E., Buys C.H., Hofstra R., Kruijer W. MEN2A-RET-induced cellular transformation by activation of STAT3. Oncogene 2001, 20:5350-5358.
20. Plaza-Menacho I., van der Sluis T., Hollema H., Gimm O., Buys C.H., Magee A.I., Isacke C.M., Hofstra R.M., Eggen B.J. Ras/ERK1/2-mediated STAT3 Ser727 phosphorylation by familial medullary thyroid carcinoma-associated RET mutants induces full activation of STAT3 and is required for c-fos promoter activation, cell mitogenicity, and transformation. J. Biol. Chem. 2007, 282:6415-6424.
21. Hwang J.H., Kim D.W., Suh J.M., Kim H., Song J.H., Hwang E.S., Park K.C., Chung H.K., Kim J.M., Lee T.H., Yu D.Y., Shong M. Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation. Mol. Endocrinol. 2003, 17:1155-1166.
22. Plaza Menacho I., Koster R., van der Sloot A.M., Quax W.J., Osinga J., van der Sluis T., Hollema H., Burzynski G.M., Gimm O., Buys C.H., Eggen B.J., Hofstra R.M. RET-familial medullary thyroid carcinoma mutants Y791F and S891A activate a Src/JAK/STAT3 pathway, independent of glial cell line-derived neurotrophic factor. Cancer Res. 2005, 65:1729-1737.
23. Zhou L., Too H.P. Mitochondrial localized STAT3 is involved in NGF induced neurite outgrowth. PLoS One 2011, 6:e21680.
24. Ramaswamy S., McBride J.L., Han I., Berry-Kravis E.M., Zhou L., Herzog C.D., Gasmi M., Bartus R.T., Kordower J.H. Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's disease. Neurobiol. Dis. 2009, 34:40-50.
25. Guschin D., Rogers N., Briscoe J., Witthuhn B., Watling D., Horn F., Pellegrini S., Yasukawa K., Heinrich P., Stark G.R., et al. A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. EMBO J. 1995, 14:1421-1429.
26. Wu Y.Y., Bradshaw R.A. Activation of the Stat3 signaling pathway is required for differentiation by interleukin-6 in PC12-E2 cells. J. Biol. Chem. 2000, 275:2147-2156.
27. Bauer J.A., Galli S., Jahn O., Hitt R., Hesse D., Opitz L., Plessmann U., Urlaub H., Poderoso J.J., Jares-Erijman E.A., Jovin T.M. A new paradigm for MAPK: structural interactions of hERK1 with mitochondria in HeLa cells. PLoS One 2009, 4:e7541.
28. Lufei C., Ma J., Huang G., Zhang T., Novotny-Diermayr V., Ong C.T., Cao X. GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction. EMBO J. 2003, 22:1325-1335.
29. Tammineni P., Anugula C., Mohammed F., Anjaneyulu M., Larner A.C., Sepuri N.B. The import of the transcription factor STAT3 into mitochondria depends on GRIM-19, a component of the electron transport chain. J. Biol. Chem. 2012.
30. Gough D.J., Corlett A., Schlessinger K., Wegrzyn J., Larner A.C., Levy D.E. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 2009, 324:1713-1716.
31. Wang E.T., Sandberg R., Luo S., Khrebtukova I., Zhang L., Mayr C., Kingsmore S.F., Schroth G.P., Burge C.B. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456:470-476.
32. Lee C.J., Irizarry K. Alternative splicing in the nervous system: an emerging source of diversity and regulation. Biol. Psychiatry 2003, 54:771-776.
33. Kan Z., Garrett-Engele P.W., Johnson J.M., Castle J.C. Evolutionarily conserved and diverged alternative splicing events show different expression and functional profiles. Nucleic Acids Res. 2005, 33:5659-5666.
34. Too H.P. Real time PCR quantification of GFRalpha-2 alternatively spliced isoforms in murine brain and peripheral tissues. Brain Res. Mol. Brain Res. 2003, 114:146-153.
35. Voikar V., Rossi J., Rauvala H., Airaksinen M.S. Impaired behavioural flexibility and memory in mice lacking GDNF family receptor alpha2. Eur. J. Neurosci. 2004, 20:308-312.
36. Devarajan E., Huang S. STAT3 as a central regulator of tumor metastases. Curr. Mol. Med. 2009, 9:626-633.
37. Yu H., Pardoll D., Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 2009, 9:798-809.
38. Yu T., Scully S., Yu Y., Fox G.M., Jing S., Zhou R. Expression of GDNF family receptor components during development: implications in the mechanisms of interaction. J. Neurosci. 1998, 18:4684-4696.
39. Trupp M., Belluardo N., Funakoshi H., Ibanez C.F. Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS. J. Neurosci. 1997, 17:3554-3567.
40. Arvidsson A., Kokaia Z., Airaksinen M.S., Saarma M., Lindvall O. Stroke induces widespread changes of gene expression for glial cell line-derived neurotrophic factor family receptors in the adult rat brain. Neuroscience 2001, 106:27-41.
41. Lundgren T.K., Nakahata K., Fritz N., Rebellato P., Zhang S., Uhlen P. RET PLCgamma phosphotyrosine binding domain regulates Ca2+ signaling and neocortical neuronal migration. PLoS One 2012, 7:e31258.
42. Airaksinen M.S., Titievsky A., Saarma M. GDNF family neurotrophic factor signaling: four masters, one servant?. Mol. Cell. Neurosci. 1999, 13:313-325.
43. Leppanen V.M., Bespalov M.M., Runeberg-Roos P., Puurand U., Merits A., Saarma M., Goldman A. The structure of GFRalpha1 domain 3 reveals new insights into GDNF binding and RET activation. EMBO J. 2004, 23:1452-1462.
44. Parkash V., Leppanen V.M., Virtanen H., Jurvansuu J.M., Bespalov M.M., Sidorova Y.A., Runeberg-Roos P., Saarma M., Goldman A. The structure of the glial cell line-derived neurotrophic factor-coreceptor complex: insights into RET signaling and heparin binding. J. Biol. Chem. 2008, 283:35164-35172.
45. Scott R.P., Ibanez C.F. Determinants of ligand binding specificity in the glial cell line-derived neurotrophic factor family receptor alpha S. J. Biol. Chem. 2001, 276:1450-1458.
46. Amoresano A., Incoronato M., Monti G., Pucci P., de Franciscis V., Cerchia L. Direct interactions among Ret, GDNF and GFRalpha1 molecules reveal new insights into the assembly of a functional three-protein complex. Cell. Signal. 2005, 17:717-727.
47. Sjostrand D., Carlsson J., Paratcha G., Persson B., Ibanez C.F. Disruption of the GDNF binding site in NCAM dissociates ligand binding and homophilic cell adhesion. J. Biol. Chem. 2007, 282:12734-12740.
48. Wan G., Too H.P. A specific isoform of glial cell line-derived neurotrophic factor family receptor alpha 1 regulates RhoA expression and glioma cell migration. J. Neurochem. 2010, 115:759-770.
49. Schuetz G., Rosario M., Grimm J., Boeckers T.M., Gundelfinger E.D., Birchmeier W. The neuronal scaffold protein Shank3 mediates signaling and biological function of the receptor tyrosine kinase Ret in epithelial cells. J. Cell Biol. 2004, 167:945-952.
50. Lee D.C., Chan K.W., Chan S.Y. RET receptor tyrosine kinase isoforms in kidney function and disease. Oncogene 2002, 21:5582-5592.
51. Borrello M.G., Mercalli E., Perego C., Degl'Innocenti D., Ghizzoni S., Arighi E., Eroini B., Rizzetti M.G., Pierotti M.A. Differential interaction of Enigma protein with the two RET isoforms. Biochem. Biophys. Res. Commun. 2002, 296:515-522.
52. Scott R.P., Eketjall S., Aineskog H., Ibanez C.F. Distinct turnover of alternatively spliced isoforms of the RET kinase receptor mediated by differential recruitment of the Cbl ubiquitin ligase. J. Biol. Chem. 2005, 280:13442-13449.
53. Hollenbeck P.J., Saxton W.M. The axonal transport of mitochondria. J. Cell Sci. 2005, 118:5411-5419.
54. Ruthel G., Hollenbeck P.J. Response of mitochondrial traffic to axon determination and differential branch growth. J. Neurosci. 2003, 23:8618-8624.
55. Verburg J., Hollenbeck P.J. Mitochondrial membrane potential in axons increases with local nerve growth factor or semaphorin signaling. J. Neurosci. 2008, 28:8306-8315.